IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q4 2024 Holdings

Filed 2025-02-13 | 11 holdings | $101.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$70.1M5,664,54868.8%
TG Therapeutics Inc(TGTX)COM88322Q108$4.9M161,6004.8%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$4.8M385,6804.8%
Invivyd Inc(IVVD)COM00534A102$4.1M9,248,2504.0%
Springworks Therapeutics IncCOM85205L107$4.0M110,4003.9%
Fractyl Health Inc(GUTS)COM35168W103$3.8M1,856,1173.8%
Bridgebio Pharma Inc(BBIO)COM10806X102$3.3M121,2003.3%
Proqr Thrapeutics N VSHS EURON71542109$2.7M1,019,4982.7%
Curis Inc(CRIS)COM231269309$1.6M521,0591.6%
Silence Therapeutics PLC(SLN)ADS82686Q101$1.3M185,1001.3%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$1.3M67,4001.2%